Physician profile
Keith A Watson
NPI 1386623817
$1,258.82
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $763 · 2021: $150 · 2022: $346.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $239.56 | 2019-2021 | |
| Conmed Corporation | $171.67 | 2019 | |
| Myovant Sciences INC. | $125.00 | 2022 | |
| Abbvie INC. | $122.65 | 2022 | |
| Lupin INC. | $122.02 | 2019 | |
| Amgen INC. | $109.70 | 2019 | |
| Therapeuticsmd, INC. | $106.37 | 2019 | |
| Medicem INC. | $98.11 | 2022 | |
| Hologic Sales and Service, LLC | $77.83 | 2019 | |
| Ethicon US, LLC | $57.66 | 2019 | |
| Gynesonics, INC. | $28.25 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.